Chinese Contract Drugmaker Pharmaron Plans Hong Kong Listing

(Bloomberg) -- Pharmaron Beijing Co. is planning a Hong Kong share sale only six months after the contract drugmaker went public in China, according to people with knowledge of the matter.

Bloomberg Quint

Add BloombergQuint App to Home screen.